Styers Melanie L, Kowalczyk Andrew P, Faundez Victor
Graduate Program in Biochemistry, Cell, and Developmental Biology, Emory University, Atlanta, GA 30322, USA.
J Cell Sci. 2006 Sep 1;119(Pt 17):3643-54. doi: 10.1242/jcs.03147. Epub 2006 Aug 15.
Intermediate filaments are required for proper membrane protein trafficking. However, it remains unclear whether perturbations in vesicular membrane transport result in changes in the architecture of the vimentin cytoskeleton. We find that treatment of cells with Brefeldin A, an inhibitor of specific stages of membrane transport, causes changes in the organization of vimentin filaments. These changes arise from movement of pre-existing filaments. Brefeldin A treatment also leads to alterations in the microtubule cytoskeleton. However, this effect is not observed in cells lacking intermediate filaments, indicating that microtubule bundling is downstream of perturbations in the vimentin cytoskeleton. Brefeldin A-induced changes in vimentin architecture are probably mediated through its effects on ADP-ribosylation factor 1 (ARF1). Expression of a dominant-negative mutant of ARF1 induces BFA-like modifications in vimentin morphology. The BFA-dependent changes in vimentin architecture occurred concurrently with the release of the ARF1-regulated adaptor complexes AP-3 and AP-1 from membranes and adaptor redistribution to vimentin networks. These observations indicate that perturbation of the vesicular membrane transport machinery lead to reciprocal changes in the architecture of vimentin networks.
正确的膜蛋白运输需要中间丝。然而,尚不清楚囊泡膜运输的扰动是否会导致波形蛋白细胞骨架结构的变化。我们发现,用布雷菲德菌素A(一种膜运输特定阶段的抑制剂)处理细胞会导致波形蛋白丝的组织发生变化。这些变化源于现有丝的移动。布雷菲德菌素A处理还会导致微管细胞骨架的改变。然而,在缺乏中间丝的细胞中未观察到这种效应,这表明微管束集在波形蛋白细胞骨架扰动的下游。布雷菲德菌素A诱导的波形蛋白结构变化可能是通过其对ADP核糖基化因子1(ARF1)的作用介导的。ARF1显性负性突变体的表达诱导波形蛋白形态发生类似布雷菲德菌素A的修饰。波形蛋白结构中依赖布雷菲德菌素A的变化与ARF1调节的衔接复合物AP-3和AP-1从膜上释放以及衔接蛋白重新分布到波形蛋白网络同时发生。这些观察结果表明,囊泡膜运输机制的扰动会导致波形蛋白网络结构的相互变化。